Sign in
BZYR Stock Price, Chart, Stats & News
Burzynski Research Institute, Inc.
Save
Burzynski Research Institute, Inc. (BZYR) does not currently pay a dividend.
262,897
Market cap
–
Current P/E
–
Forward P/E
BZYR chart
About
Health care
Sector
Medical - Pharmaceuticals
Industry
Burzynski Research Institute, Inc. engages in the research and development of antineoplaston drugs for the treatment of various cancers. The company is involved in the research, production, marketing, promotion, and sale of medical chemical compounds composed of growth-inhibiting peptides, amino acid derivatives, and organic acids under the Antineoplastons trade name. It also offers consulting services.
Similar securities
Based on sector and market capitalization
Report issue